The action of existing and potential drugs on molecular and immune systems. New targets for drug action generated by new movements in science.
If you are interested in drug design and analysing drug action from a cell-signalling and molecular perspective, then this paper will be of interest to you.
| Paper title | Molecular and Immunopharmacology |
|---|---|
| Paper code | PHAL305 |
| Subject | Pharmacology |
| EFTS | 0.15 |
| Points | 18 points |
| Teaching period | Semester 1 (On campus) |
| Domestic Tuition Fees (NZD) | $1,141.35 |
| International Tuition Fees | Tuition Fees for international students are elsewhere on this website. |
- Prerequisite
- (BIOC 111 or BIOC 192) and (CHEM 112 or CHEM 191) and two of BIOL 111, BIOL 115, CELS 191, HUBS 191, HUBS 192, and 18 further 200-level , ANAT, BIOC, GENE, MICR, PHAL or PHSL points
- Schedule C
- Science
- Contact
Dr Greg Giles (greg.giles@otago.ac.nz)
- Teaching staff
Dr Greg Giles
Associate Professor Lyn Wise
Dr Sarah Baird
Professor Michelle Glass
Professor Debbie Hay- Paper Structure
Assessment:
- Final Exam 65%
- Practical Report 25%
- Workshop 10%
- Textbooks
- Students should concentrate on the lecture notes.
- Graduate Attributes Emphasised
- Interdisciplinary perspective, Lifelong learning, Scholarship, Critical thinking,
Research, Self-motivation, Teamwork.
View more information about Otago's graduate attributes. - Learning Outcomes
Students who successfully complete this paper will:
- Demonstrate awareness of current approaches to drug discovery
- Describe methods used for drug discovery and development
- Demonstrate knowledge of basic cellular and molecular processes in cancer, infection and autoimmune disease
- Critically analyse these pathways for their potential as drug targets
- Interpret information and data from historical and scientific literature
- Design, execute, analyse and present original laboratory-based scientific research
- Communicate knowledge and findings using verbal, written and visual means
